Ireland· IE-PA-EU/1/14/938/001
Zydelig 100 mg film-coated tablets
A idelalisib product containing idelalisib, registered in Ireland by Gilead Sciences Ireland UC.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Idelalisib
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Ireland (IE)
- ATC code
- L01XX47
- ATC class
- Idelalisib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/938/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
820 interactions on record for idelalisib.
Graded by severity as the source publishes them — 236 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Idelalisib · interactions on record
820 records
- 236 severe
- 568 moderate
- 16 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- BudesonideA07EA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Idelalisib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZydeligParanova Oy
- United StatesZydeligGilead Sciences, Inc.
- CzechiaZYDELIGGilead Sciences Ireland UC, Carrigtohill
- SpainZydelig 100 mg comprimidos recubiertos con peliculaGilead Sciences Ireland Unlimited Company
- BelgiumZydelig 100 mgGilead Sciences Ireland UC
- IcelandZydeligGilead Sciences Ireland UC*
- NetherlandsZydelig 100 mg, filmomhulde tabletGilead Sciences Ireland UC
- NorwayZydeligGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zydelig
- Liechtenstein · Zydelig
- Norway · Zydelig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5a5bcec-132e-44a4-9a23-78901bbc2b6e GET /v1/drugs/c5a5bcec-132e-44a4-9a23-78901bbc2b6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XX",
"L01XX47"
],
"strength": null,
"pa_number": "EU/1/14/938/001",
"substances": [
"Idelalisib"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "18/09/2014",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about idelalisib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.